Niger: Elevated meningococcal disease activity reported in Zinder Region through February

Event

Health officials continue to report elevated meningococcal disease activity in Zinder Region, with more than 910 cases reported Nov. 1, 2022- Feb. 26, 2023. This compared to 231 cases reported over a similar period in 2021. Dungass (342 cases) is the most affected health district, followed by Matameye (98 cases), Mirriah (72 cases), and Magaria (38 cases). Health authorities have implemented a reactive vaccination campaign in the region. This represents the most complete data available as of April 12.

Context

Meningococcal disease is a significant public health problem in Africa, especially in countries that lie along the meningitis belt. Part of Niger is located in Africa’s meningitis belt and risk of infection exists nationwide, year-round, however epidemics are most common from January-June. Niger reported 589 cases of meningococcal disease in 2020, and 1,172 cases in 2019.

Meningococcal disease, also called bacterial meningitis, is a bacterial disease that spreads through respiratory droplets created when an infected individual coughs, sneezes, or speaks. Disease transmission usually requires close or lengthy contact with an infected individual. Symptoms typically appear 3-4 days after exposure, but can develop up to 10 days after exposure. The most common symptoms of meningococcal disease are stiff neck, high fever, sensitivity to light, confusion, headaches, and vomiting.

Advice

Visit a doctor to ensure vaccination against meningococcal disease. Practice basic health precautions. Seek medical attention if symptoms develop within two weeks of being in affected areas.